Novavax
NVAX
#5751
Rank
A$1.69 B
Marketcap
A$10.46
Share price
0.73%
Change (1 day)
-18.72%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of September 2025 : -A$0.24 Billion

According to Novavax's latest financial reports the company has -A$0.24 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$1.01 Billion-4.69%
2023-12-31$-A$1.06 Billion12.93%
2022-12-31$-A$0.94 Billion92.09%
2021-12-31$-A$0.49 Billion-159.47%
2020-12-31$A$0.81 B-407.01%
2019-12-31$-A$0.27 Billion11.45%
2018-12-31$-A$0.24 Billion82.94%
2017-12-31$-A$0.14 Billion1593.65%
2016-12-31$-A$7.7 Million-101.92%
2015-12-31$A$0.40 B43.19%
2014-12-31$A$0.28 B23.14%
2013-12-31$A$0.22 B195.09%
2012-12-31$A$77.21 M47.02%
2011-12-31$A$52.51 M-9.66%
2010-12-31$A$58.13 M-25.35%
2009-12-31$A$77.87 M20.77%
2008-12-31$A$64.47 M-10.62%
2007-12-31$A$72.13 M-39.51%
2006-12-31$A$0.11 B75.73%
2005-12-31$A$67.85 M57.78%
2004-12-31$A$43 M-11.06%
2003-12-31$A$48.35 M237.48%
2002-12-31$A$14.32 M-73.4%
2001-12-31$A$53.87 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-A$0.43 Billion 79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.99 B-942.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.88 B-471.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.59 Billion 147.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$69.58 B-29,442.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$140.91 B-59,520.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$67.74 B-28,664.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
A$11.37 M-104.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$32.05 B-13,616.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
A$0.90 B-481.92%๐Ÿ‡บ๐Ÿ‡ธ USA